Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR2 | P41587 | 8/20 | 0.55 |
| ▸ | VIPR1 | P32241 | 7/20 | 0.55 |
| ▸ | BACE1 | P56817 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30183030 | 0.98 | VIPR2 (0.54) | VIPR2VIPR1BACE1 | |
| SCHEMBL30183023 | 0.96 | VIPR2 (0.51) | VIPR2VIPR1BACE1 | |
| SCHEMBL30182861 | 0.94 | VIPR2 (0.54) | VIPR2VIPR1 | |
| SCHEMBL30182744 | 0.93 | VIPR2 (0.51) | VIPR2VIPR1 | |
| SCHEMBL29406555 | 0.93 | VIPR2 (0.49) | VIPR2VIPR1BACE1 | |
| SCHEMBL29500481 | 0.93 | VIPR2 (0.49) | VIPR2VIPR1BACE1 | |
| SCHEMBL30804669 | 0.93 | VIPR2 (0.48) | VIPR2VIPR1BACE1 | |
| SCHEMBL30512671 | 0.93 | ENPEP (0.50) | VIPR2VIPR1BACE1 | |
| SCHEMBL30046096 | 0.91 | ENPEP (0.50) | VIPR2VIPR1BACE1 | |
| SCHEMBL31257025 | 0.91 | BACE1 (0.49) | VIPR2VIPR1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11604185-B2 | Methods for detection of botulinum neurotoxin | CITY OF HOPE (US) | 2023-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11604185-B2 | Methods for detection of botulinum neurotoxin | ANTXR2, INHA, PRSS12 | VIPR2 954/4885VIPR1 753/4885BACE1 329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.